N2:BIODRG

By Manas Mishra (Reuters) - The Russian invasion of Ukraine has left drugmakers scrambling to find ways for patients enrolled...

TAIPEI (Reuters) -Taiwan Vice President William Lai used his final day in the United States to repeat an accusation that...

JERUSALEM (Reuters) - Israel on Wednesday broadened eligibility for a fourth dose of COVID-19 vaccine to include adults under 60...

(Reuters) - Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron...

COPENHAGEN (Reuters) - Getting a third dose of either Pfizer-BioNTech's or Moderna's COVID-19 vaccine offers a "significant increase" in protection...

By Michael Erman (Reuters) -Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be...

(Reuters) - The upcoming New Year's Eve will mark the second anniversary of the first reported COVID-19 case in Wuhan,...

By Emilio Parodi MILAN (Reuters) - The EU drug regulator will not decide whether to approve Merck & Co's COVID-19...

By Francesco Guarascio and Panu Wongcha-um BRUSSELS/BANGKOK (Reuters) - Tens of millions of migrants may be denied COVID-19 vaccines from...

(Reuters) - The European Union's drug regulator on Wednesday recommended that a booster dose of Johnson & Johnson's COVID-19 shot...

By Francesco Guarascio BRUSSELS (Reuters) - Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19...

By Alexander Winning and Wendell Roelf JOHANNESBURG (Reuters) - Pfizer-BioNTech's COVID-19 vaccine has been less effective in South Africa at...

By Ludwig Burger FRANKFURT (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose...

By Ludwig Burger and Michael Erman (Reuters) -BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine...

By Julie Steenhuysen (Reuters) - Arrival of the highly-mutated Omicron variant is a wake-up call to develop vaccines less susceptible...

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - The German state of Saxony, among the hardest hit by surging...

By Promit Mukherjee and Trevor Hunnicutt JOHANNESBURG/WASHINGTON (Reuters) - Heavily mutated Omicron is rapidly becoming the dominant variant of the...

By Stephanie Nebehay GENEVA (Reuters) - As children and adolescents are at lower risk of severe COVID-19 disease, countries should...

By Maayan Lubell JERUSALEM (Reuters) -Israel began rolling out Pfizer/BioNtech COVID-19 vaccinations for 5- to 11-year-olds on Monday hoping to...

BERLIN (Reuters) - Legalising cannabis could bring Germany annual tax revenues and cost savings of about 4.7 billion euros ($5.34...